MPN Advances Day 2019 E-Learning
View e-learning webcasts on myeloproliferative neoplasms here!
ASH 2019 Late-Breaking Abstracts
VJHemOnc are excited to present the incredibly exciting late-breaking research presented at this years American Society of Hematology (ASH) 2019…
iwCAR-T 2019 e-learning
VJHemOnc is pleased to bring you e-learning webcasts from iwCAR-T 2019– explore updates in CAR T-cell therapy!
The Video Journal of Hematological Oncology (VJHemOnc) is pleased to share the success of the PROMISE study by the Dana-Faber…
The REAL classification of lymphoma
Twenty-five years ago, almost to the day, there was a paradigm shift in the classification of lymphoma.
Selinexor granted accelerated FDA approval for multiple myeloma
The pivotal STORM study (NCT02336815) welcomed selinexor (Xpovio), in combination with low-dose dexamethasone, into the treatment line for quad/penta-refractory multiple…